TSHA Taysha Gene Therapies, Inc. - Common Stock
$6,17
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 11, 2026
52 Haftlık Aralık
$3–$7
75% of range
Analist Derecelendirmesi
BUY
18 analysts
Fiyat Hedefi
$13
+116% upside
P/E (TTM)
-18.3
ROE
-44.0%
Net Kâr Marjı
-1115.3%
TSHA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$6.17
Piyasa Değeri
$1.77B
P/E (TTM)
-18.3
EPS (TTM)
$-0.34
Gelir (TTM)
$10M
Temettü Verimi
—
ROE
-44.0%
D/E Borç/Özsermaye
0.2
52 Haftlık Aralık
$3 – $7
TSHA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$10M
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.34
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-94M
2020-12-31
→
2025-12-31
Marjlar
-1115.3%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
TSHA
Akran Ortalaması
P/E (TTM)
-18.3
27.2
P/S (TTM) (F/S (TTM))
181.4
25.4
P/B (F/D)
7.2
5.1
EV / EBITDA
-13.6
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-18.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
TSHA
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-1130.7%
—
Net Profit Margin (Net Kâr Marjı)
-1115.3%
-473.7%
ROA
-43.3%
-40.2%
ROE
-44.0%
-50.4%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
TSHA
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.2
—
Current Ratio (Cari Oran)
12.2
9.0
Quick Ratio (Cari Oran)
12.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
TSHA
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
17.3%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
57.5%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
TSHA
Akran Ortalaması
TSHA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
18 analist
- Güçlü Al 6 33,3%
- Al 11 61,1%
- Tut 1 5,6%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
12 analist · 2026-08-16
Medyan
$12.50
Ortalama
$13.33
← Tüm hedeflerin altında
$6.17
Düşük
$10.00
Yüksek
$19.00
Medyan hedef
$12.50
+102,6%
Ortalama hedef
$13.33
+116,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.00%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.13 | $-0.12 | -0.01% |
| 31 Mart 2026 | $-0.12 | $-0.10 | -0.02% |
| 31 Aralık 2025 | $-0.08 | $-0.10 | 0.02% |
| 30 Eylül 2025 | $-0.09 | $-0.09 | 0.00% |
| 30 Haziran 2025 | $-0.09 | $-0.08 | -0.01% |
| 31 Mart 2025 | $-0.08 | $-0.09 | 0.01% |
| 31 Aralık 2024 | $-0.07 | $-0.08 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $10M | $8M | $15M | $3M | |
| R&D Expense | $86M | $66M | $57M | $91M | |
| SG&A Expense | $34M | $29M | $30M | $37M | |
| Operating Expenses | $120M | $100M | $88M | $165M | |
| Operating Income | $-110M | $-91M | $-72M | $-162M | |
| Interest Expense | · | · | $5M | $4M | |
| Interest Income | $9M | $7M | $4M | · | |
| Other Non-op | $-291.0K | $-110.0K | $-47.0K | $-18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-109M | $-89M | $-112M | $-166M | |
| EPS (Basic) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| EPS (Diluted) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| Shares (Basic) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| Shares (Diluted) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| EBITDA | $-110M | $-91M | $-72M | · |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $320M | $139M | $144M | $88M | |
| Prepaid Expense | $4M | $3M | $3M | $9M | |
| Other Current Assets | $802.0K | $308.0K | $292.0K | $466.0K | |
| Current Assets | $325M | $142M | $150M | $96M | |
| PP&E (Net) | $7M | $7M | $11M | $15M | |
| PP&E (Gross) | $11M | $11M | $14M | $17M | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $183.0K | $217.0K | $304.0K | $1M | |
| Total Assets | $343M | $160M | $173M | $126M | |
| Accounts Payable | $6M | $4M | $6M | $11M | |
| Current Liabilities | $27M | $26M | $37M | $63M | |
| Capital Leases | $18M | $17M | $19M | $20M | |
| Other Non-current Liabilities | $2M | $1M | $2M | $4M | |
| Total Liabilities | $96M | $89M | $98M | $125M | |
| Long-term Debt | · | · | · | $38M | |
| Total Debt | $50M | $44M | $41M | · | |
| Common Stock | $3.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $958M | $678M | $588M | $402M | |
| Retained Earnings | $-711M | $-602M | $-513M | $-401M | |
| AOCI | $-192.0K | $-4M | · | · | |
| Stockholders' Equity | $247M | $72M | $75M | $949.0K | |
| Liabilities + Equity | $343M | $160M | $173M | $126M | |
| Shares Outstanding | 285,051,648 | 204,943,306 | 186,960,193 | 63,207,507 |
Nakit Akışı 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $13M | $13M | $8M | $18M | |
| Operating Cash Flow | $-93M | $-81M | $-73M | $-88M | |
| CapEx | $738.0K | $374.0K | $4M | $21M | |
| Investing Cash Flow | $-604.0K | $-363.0K | $-7M | $-25M | |
| Stock Issued | · | · | $500.0K | · | |
| Financing Cash Flow | $275M | $77M | $136M | $52M | |
| Net Change in Cash | $181M | $-5M | $56M | $-61M | |
| Free Cash Flow | $-94M | $-82M | $-77M | · |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -1130.7% | -1097.5% | -468.8% | · | |
| Net Margin | -1115.3% | -1071.6% | -722.1% | · | |
| EBITDA Margin | -1130.7% | -1097.5% | -468.8% | · | |
| ROA | -43.3% | -53.6% | -74.6% | · | |
| ROE | -44.0% | -111.4% | -864.1% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 12.2 | 5.4 | 4.1 | · | |
| Quick Ratio | 12.0 | 5.3 | 3.9 | · | |
| Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| LT Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| Interest Coverage | · | · | -14.5 | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 17.3% | -46.1% | 517.6% | · | |
| Revenue CAGR 3Y | 57.5% | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $10M | $8M | $15M | $3M | |
| Net Income TTM | $-109M | $-89M | $-112M | $-166M | |
| Market Cap | $1.57B | $355M | $331M | · | |
| Enterprise Value | $1.30B | $259M | $227M | · | |
| P/E | -16.2 | -4.8 | -1.8 | -0.6 | |
| P/S | 160.4 | 42.5 | 21.4 | · | |
| P/B | 6.3 | 5.0 | 4.4 | · | |
| P / Tangible Book | 6.3 | 5.0 | 4.4 | 150.5 | |
| P / Cash Flow | -16.8 | -4.4 | -4.5 | · | |
| P / FCF | -16.7 | -4.3 | -4.3 | · | |
| EV / EBITDA | -11.7 | -2.8 | -3.1 | · | |
| EV / FCF | -13.8 | -3.2 | -3.0 | · | |
| EV / Revenue | 132.8 | 31.1 | 14.7 | · | |
| Earnings Yield | -6.2% | -20.8% | -54.2% | -167.3% |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $5M | $0 | $2M | $2M | $2M | $2M | $1M | $3M | $4M | $5M | $2M | $5M | |
| R&D Expense | $39M | $34M | $25M | $26M | $20M | $16M | $15M | $15M | $15M | $21M | $13M | $12M | $20M | $13M | |
| SG&A Expense | $12M | $10M | $9M | $8M | $9M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $6M | $9M | |
| Operating Expenses | $47M | $43M | $34M | $34M | $29M | $24M | $22M | $28M | $22M | $28M | $20M | $21M | $26M | $21M | |
| Operating Income | $-47M | $-43M | $-28M | $-34M | $-27M | $-21M | $-20M | $-26M | $-21M | $-24M | $-16M | $-16M | $-23M | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | $27.0K | $29.0K | · | $1M | $1M | $1M | |
| Interest Income | $2M | $3M | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $1M | · | · | |
| Other Non-op | $-88.0K | $-31.0K | $-30.0K | $-37.0K | $-237.0K | $13.0K | $-66.0K | $-81.0K | $42.0K | $-5.0K | $-23.0K | $-19.0K | $3.0K | $-8.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income | $-47M | $-42M | $-28M | $-33M | $-27M | $-22M | $-19M | $-26M | $-21M | $-24M | $48M | $-117M | $-25M | $-18M | |
| EPS (Basic) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| EPS (Diluted) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| Shares (Basic) | 369,044,040 | 366,632,827 | -600,892,861 | 353,309,524 | 297,988,978 | 269,306,331 | -481,760,521 | 267,824,045 | 232,821,553 | 231,249,344 | -137,084,753 | 125,700,799 | 64,244,531 | 63,260,905 | |
| Shares (Diluted) | 369,044,040 | 366,632,827 | -600,892,861 | 353,309,524 | 297,988,978 | 269,306,331 | -481,760,521 | 267,824,045 | 232,821,553 | 231,249,344 | -137,084,753 | 125,700,799 | 64,244,531 | 63,260,905 | |
| EBITDA | $-47M | $-43M | · | $-34M | $-27M | $-21M | · | $-26M | $-21M | $-24M | · | $-16M | $-23M | $-17M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $455M | $277M | $320M | $297M | $313M | $117M | $139M | $158M | $173M | $124M | $144M | $164M | $45M | $63M | |
| Prepaid Expense | $6M | $5M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $6M | $9M | $9M | |
| Other Current Assets | $851.0K | $1M | $802.0K | $456.0K | $657.0K | $536.0K | $308.0K | $465.0K | $206.0K | $149.0K | $292.0K | $404.0K | $510.0K | $532.0K | |
| Current Assets | $461M | $282M | $325M | $300M | $316M | $121M | $142M | $162M | $178M | $131M | $150M | $172M | $54M | $72M | |
| PP&E (Net) | $2M | $6M | $7M | $7M | $7M | $7M | $7M | $8M | $11M | $11M | $11M | $11M | $14M | $15M | |
| PP&E (Gross) | $8M | $11M | $11M | $11M | $11M | $11M | $11M | $12M | $14M | $14M | $14M | $14M | $16M | $17M | |
| Accum. Depreciation | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-current Assets | $106.0K | $181.0K | $183.0K | $184.0K | $186.0K | $188.0K | $217.0K | $220.0K | $288.0K | $304.0K | $304.0K | $304.0K | $304.0K | $1M | |
| Total Assets | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Accounts Payable | $9M | $5M | $6M | $5M | $8M | $4M | $4M | $5M | $9M | $10M | $6M | $8M | $11M | $9M | |
| Current Liabilities | $26M | $20M | $27M | $29M | $25M | $23M | $26M | $29M | $34M | $39M | $37M | $180M | $51M | $54M | |
| Capital Leases | $6M | $18M | $18M | $17M | $17M | $17M | $17M | $18M | $18M | $18M | $19M | $19M | $20M | $20M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $4M | $4M | $4M | |
| Total Liabilities | $83M | $88M | $96M | $98M | $85M | $83M | $89M | $91M | $92M | $99M | $98M | $245M | $119M | $117M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $38M | |
| Total Debt | $49M | $49M | · | $51M | $41M | $42M | · | $43M | $38M | $41M | · | $39M | $38M | $38M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.19B | $965M | $958M | $904M | $900M | $681M | $678M | $675M | $664M | $591M | $588M | $512M | $407M | $404M | |
| Retained Earnings | $-800M | $-754M | $-711M | $-683M | $-651M | $-624M | $-602M | $-584M | $-558M | $-537M | $-513M | $-561M | $-444M | $-419M | |
| AOCI | $769.0K | $985.0K | $-192.0K | $-1M | $-699.0K | $-2M | $-4M | $-2M | $2M | $-251.0K | · | · | · | · | |
| Stockholders' Equity | $387M | $212M | $247M | $219M | $249M | $55M | $72M | $89M | $109M | $54M | $75M | $-49M | $-37M | $-15M | |
| Liabilities + Equity | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Shares Outstanding | 325,302,280 | 287,276,885 | 285,051,648 | 273,915,373 | 272,730,060 | 205,054,570 | 204,943,306 | 204,943,306 | 201,381,450 | 187,018,275 | 186,960,193 | 186,960,193 | 64,432,637 | 63,473,349 |
Nakit Akışı 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-40M | $-41M | $-27M | $-24M | $-20M | $-22M | $-18M | $-22M | $-22M | $-20M | $-16M | $-18M | $-19M | $-20M | |
| CapEx | $-1.0K | $24.0K | $250.0K | $108.0K | $2.0K | $378.0K | $-2.0K | $35.0K | $201.0K | $140.0K | $17.0K | $0 | $-48.0K | $4M | |
| Investing Cash Flow | $1.0K | $-3M | $-247.0K | $-48.0K | $62.0K | $-371.0K | $13.0K | $-35.0K | $-201.0K | $-140.0K | $-10.0K | $-3M | $48.0K | $-4M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $217M | $711.0K | $50M | $9M | $216M | $-52.0K | $-357.0K | $7M | $70M | $-22.0K | $-4M | $141M | $377.0K | $-370.0K | |
| Net Change in Cash | $176M | $-43M | $23M | $-15M | $196M | $-22M | $-19M | $-15M | $49M | $-20M | $-20M | $119M | $-18M | $-24M | |
| Free Cash Flow | · | $-41M | · | · | · | · | · | · | · | $-20M | · | · | · | $-24M |
Kârlılık 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| Net Margin | · | · | · | · | -1353.6% | -935.2% | · | -1427.5% | -1882.0% | -705.4% | · | -2467.1% | -1027.1% | -374.5% | |
| EBITDA Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| ROA | -11.6% | -19.3% | · | -13.2% | -10.1% | -14.8% | · | -13.6% | -14.8% | -18.9% | · | -76.2% | -22.0% | -13.2% | |
| ROE | -14.7% | -31.8% | · | -21.3% | -15.0% | -39.5% | · | -128.6% | -58.3% | -123.7% | · | 616.4% | 1117.1% | -98.5% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.8 | 14.0 | · | 10.5 | 12.5 | 5.4 | · | 5.5 | 5.2 | 3.4 | · | 1.0 | 1.1 | 1.3 | |
| Quick Ratio | 17.5 | 13.8 | · | 10.4 | 12.3 | 5.2 | · | 5.4 | 5.1 | 3.2 | · | 0.9 | 0.9 | 1.2 | |
| Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| LT Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -788.9 | -839.0 | · | -11.0 | -16.2 | -12.1 |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | · | $6M | $7M | $9M | · | $11M | $12M | $15M | · | · | · | · | |
| Net Income TTM | $-149M | $-124M | · | $-107M | $-95M | $-92M | · | $-188M | $-187M | $-183M | · | $-186M | $-103M | $-129M | |
| Market Cap | $2.22B | $1.28B | · | $896M | $630M | $285M | · | $412M | $451M | $537M | · | $591M | $43M | $51M | |
| Enterprise Value | $1.81B | $1.06B | · | $649M | $358M | $211M | · | $297M | $316M | $453M | · | $465M | $36M | $25M | |
| P/E | -15.8 | -11.8 | · | -9.1 | -6.4 | -3.8 | · | -1.6 | -1.5 | -1.7 | · | -1.4 | -0.3 | -0.3 | |
| P/S | 1115.5 | 299.5 | · | 147.4 | 87.6 | 33.1 | · | 37.3 | 38.7 | 35.2 | · | · | · | · | |
| P/B | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | -12.0 | -1.1 | -3.4 | |
| P / Tangible Book | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | · | · | · | |
| P / Cash Flow | · | -31.4 | · | · | · | -12.9 | · | · | · | -27.1 | · | · | · | -2.5 | |
| P / FCF | · | -31.4 | · | · | · | · | · | · | · | -26.9 | · | · | · | -2.1 | |
| EV / EBITDA | -38.2 | -24.3 | · | -19.1 | -13.4 | -9.8 | · | -11.5 | -14.8 | -18.6 | · | -28.6 | -1.5 | -1.5 | |
| EV / FCF | · | -25.8 | · | · | · | · | · | · | · | -22.7 | · | · | · | -1.1 | |
| EV / Revenue | 911.0 | 246.4 | · | 106.8 | 49.8 | 24.5 | · | 26.9 | 27.1 | 29.7 | · | · | · | · | |
| Earnings Yield | -6.3% | -8.5% | · | -11.0% | -15.6% | -26.6% | · | -60.7% | -67.0% | -58.9% | · | -70.9% | -326.8% | -388.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $10M | $8M | $15M | $3M | — |
| Faaliyet Kâr Marjı % | -1130.7% | -1097.5% | -468.8% | — | — |
| Net Gelir | $-109M | $-89M | $-112M | $-166M | $-175M |
| Seyreltilmiş Hisse Başı Kâr | $-0.34 | $-0.36 | $-0.96 | $-3.78 | $-4.64 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | 0.6 | 0.5 | — | 0.4 |
| Cari Oran | 12.2 | 5.4 | 4.1 | — | 3.1 |
| Cari Oran | 12.0 | 5.3 | 3.9 | — | 2.9 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-94M | $-82M | $-77M | — | $-132M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 224 dosya · $1.7B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 48 (+20 önceki Ç'ye göre) | 23 (-7 önceki Ç'ye göre) | 90 (+26 önceki Ç'ye göre) | 42 (-13 önceki Ç'ye göre) | +44.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $162.683.327 | 23.888.888 | 9,61% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $160.413.963 | 23.555.648 | 9,48% | Hisse senetleri |
| Vestal Point Capital, LP | $132.216.150 | 19.415.000 | 7,81% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $92.490.887 | 13.581.628 | 5,46% | Hisse senetleri |
| RTW INVESTMENTS, LP | $92.345.357 | 13.560.258 | 5,46% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.979.232 | 12.478.595 | 5,02% | Hisse senetleri |
| STATE STREET CORP | $77.783.275 | 11.421.920 | 4,59% | Hisse senetleri |
| Siren, L.L.C. | $67.055.203 | 9.846.579 | 3,96% | Hisse senetleri |
| Octagon Capital Advisors LP | $66.010.992 | 9.693.244 | 3,90% | Hisse senetleri |
| VANGUARD GROUP INC | $63.339.386 | 11.516.252 | 3,74% | Hisse senetleri |
| FMR LLC | $53.647.634 | 7.877.773 | 3,17% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $38.279.203 | 5.619.701 | 2,26% | Hisse senetleri |
| Polar Capital Holdings Plc | $34.847.676 | 5.117.133 | 2,06% | Hisse senetleri |
| MPM BIOIMPACT LLC | $30.645.000 | 4.500.000 | 1,81% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $27.272.388 | 4.004.756 | 1,61% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $26.460.262 | 3.885.501 | 1,56% | Hisse senetleri |
| GordonMD Global Investments LP | $24.501.508 | 723.185 | 1,45% | Hisse senetleri |
| Casdin Capital, LLC | $22.132.500 | 3.250.000 | 1,31% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.383.461 | 3.140.009 | 1,26% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $20.705.573 | 3.040.466 | 1,22% | Hisse senetleri |
| Pictet Asset Management Holding SA | $18.868.474 | 2.770.701 | 1,11% | Hisse senetleri |
| Aberdeen Group plc | $15.847.905 | 2.327.152 | 0,94% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $15.761.752 | 2.314.501 | 0,93% | Hisse senetleri |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $15.322.500 | 2.250.000 | 0,91% | Hisse senetleri |
| NORGES BANK | $15.210.816 | 2.233.600 | 0,90% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.986.733 | 2.200.695 | 0,89% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $14.483.767 | 2.126.838 | 0,86% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $13.620.000 | 2.000.000 | 0,80% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $13.567.079 | 1.992.229 | 0,80% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $12.914.988 | 1.896.474 | 0,76% | Hisse senetleri |
| B Group, Inc. | $12.261.786 | 1.800.556 | 0,72% | Hisse senetleri |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $12.099.000 | 3.700.000 | 0,71% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $11.917.500 | 1.750.000 | 0,70% | Hisse senetleri |
| BARCLAYS PLC | $11.020.670 | 1.618.307 | 0,65% | Hisse senetleri |
| HEIGHTS CAPITAL MANAGEMENT, INC | $10.215.000 | 1.500.000 | 0,60% | Hisse senetleri |
| Seven Fleet Capital Management LP | $9.940.323 | 1.504.400 | 0,59% | Hisse senetleri |
| Palo Alto Investors LP | $9.475.311 | 1.391.382 | 0,56% | Hisse senetleri |
| Granahan Investment Management, LLC | $8.888.255 | 1.305.177 | 0,53% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $8.103.178 | 1.189.894 | 0,48% | Hisse senetleri |
| CITADEL ADVISORS LLC | $7.471.292 | 1.097.106 | 0,44% | Hisse senetleri |
| Quantum Private Wealth, LLC | $5.529.903 | 812.027 | 0,33% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $5.387.860 | 791.169 | 0,32% | Hisse senetleri |
| Sands Capital Alternatives, LLC | $4.936.385 | 724.873 | 0,29% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $4.871.997 | 715.418 | 0,29% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $4.358.638 | 640.035 | 0,26% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $4.020.535 | 590.387 | 0,24% | Hisse senetleri |
| AFFINITY WEALTH MANAGEMENT LLC | $3.928.062 | 576.808 | 0,23% | Hisse senetleri |
| Squarepoint Ops LLC | $3.876.722 | 569.269 | 0,23% | Hisse senetleri |
| ACUTA CAPITAL PARTNERS, LLC | $3.825.912 | 561.808 | 0,23% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.799.980 | 558.000 | 0,22% | Alım opsiyonu |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.765.930 | 553.000 | 0,22% | Hisse senetleri |
| DIADEMA PARTNERS LP | $3.559.035 | 522.619 | 0,21% | Hisse senetleri |
| Woodline Partners LP | $3.499.169 | 513.828 | 0,21% | Hisse senetleri |
| Holocene Advisors, LP | $3.473.100 | 510.000 | 0,21% | Hisse senetleri |
| Ghisallo Capital Management LLC | $3.439.050 | 505.000 | 0,20% | Hisse senetleri |
| Burkehill Global Management, LP | $3.405.000 | 500.000 | 0,20% | Hisse senetleri |
| POLEN CAPITAL MANAGEMENT LLC | $3.331.581 | 489.219 | 0,20% | Hisse senetleri |
| Trexquant Investment LP | $2.584.919 | 379.577 | 0,15% | Hisse senetleri |
| Swiss National Bank | $2.512.890 | 369.000 | 0,15% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $2.440.527 | 358.374 | 0,14% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $2.371.603 | 348.253 | 0,14% | Hisse senetleri |
| Jefferies Financial Group Inc. | $2.239.128 | 328.800 | 0,13% | Hisse senetleri |
| RHUMBLINE ADVISERS | $2.042.820 | 299.975 | 0,12% | Hisse senetleri |
| CITIGROUP INC | $1.995.800 | 293.069 | 0,12% | Hisse senetleri |
| ALPS ADVISORS INC | $1.978.598 | 290.543 | 0,12% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $1.790.322 | 262.896 | 0,11% | Hisse senetleri |
| Qube Research & Technologies Ltd | $1.767.910 | 259.605 | 0,10% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $1.702.500 | 250.000 | 0,10% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.660.258 | 243.797 | 0,10% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.598.416 | 234.716 | 0,09% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.489.565 | 218.732 | 0,09% | Hisse senetleri |
| ORACLE INVESTMENT MANAGEMENT INC | $1.457.500 | 265.000 | 0,09% | Hisse senetleri |
| BlackRock, Inc. | $1.411.468 | 207.264 | 0,08% | Hisse senetleri |
| Monashee Investment Management LLC | $1.362.000 | 200.000 | 0,08% | Hisse senetleri |
| Privium Fund Management B.V. | $1.354.509 | 198.900 | 0,08% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $1.345.506 | 197.578 | 0,08% | Hisse senetleri |
| Chicago Partners Investment Group LLC | $1.296.283 | 222.347 | 0,08% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.289.351 | 189.332 | 0,08% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.205.976 | 177.089 | 0,07% | Hisse senetleri |
| MORGAN STANLEY | $1.204.212 | 176.830 | 0,07% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $1.107.130 | 247.680 | 0,07% | Hisse senetleri |
| WEXFORD CAPITAL LP | $1.094.054 | 160.654 | 0,06% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.054.045 | 154.779 | 0,06% | Hisse senetleri |
| Rafferty Asset Management, LLC | $1.053.548 | 154.706 | 0,06% | Hisse senetleri |
| Palumbo Wealth Management LLC | $1.015.869 | 149.173 | 0,06% | Hisse senetleri |
| MetLife Investment Management, LLC | $959.161 | 140.846 | 0,06% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $911.321 | 133.821 | 0,05% | Hisse senetleri |
| Persistent Asset Partners Ltd | $908.529 | 133.411 | 0,05% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $903.101 | 132.614 | 0,05% | Hisse senetleri |
| Mariner, LLC | $793.923 | 116.582 | 0,05% | Hisse senetleri |
| CITADEL ADVISORS LLC | $783.150 | 115.000 | 0,05% | Alım opsiyonu |
| TWO SIGMA ADVISERS, LP | $767.696 | 139.581 | 0,05% | Hisse senetleri |
| Aquatic Capital Management LLC | $736.896 | 108.208 | 0,04% | Hisse senetleri |
| Engineers Gate Manager LP | $709.139 | 104.132 | 0,04% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $708.887 | 104.095 | 0,04% | Hisse senetleri |
| XTX Topco Ltd | $689.138 | 101.195 | 0,04% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $669.736 | 98.346 | 0,04% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $663.294 | 97.400 | 0,04% | Satım opsiyonu |
| Invesco Ltd. | $650.055 | 95.456 | 0,04% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $612.091 | 136.933 | 0,04% | Hisse senetleri |
Şirket yöneticileri 11 içeriden öğrenenler · 4 yöneticiler · 7 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Sean P. Nolan | Chief Executive Officer | 02 Ocak 2024 A | 1.185.858 | 0 | 0 | $0 |
| Kamran Alam | Chief Financial Officer | 02 Ocak 2024 A | 842.225 | 0 | 0 | $0 |
| Sukumar Nagendran | President and Head of R&D | 02 Ocak 2024 A | 897.843 | 0 | 0 | $0 |
| Suyash Prasad | CMO and Head of R&D | 06 Temmuz 2022 S | 530.589 | 0 | 0 | $0 |
| Alison S Long | Yönetim kurulu üyesi | 01 Kasım 2023 A | — | 0 | 0 | $0 |
| John A Stalfort III | Yönetim kurulu üyesi | 16 Ağustos 2023 G | 1.049.381 | 0 | 0 | $0 |
| Phillip B. Donenberg | Yönetim kurulu üyesi | 16 Ağustos 2023 P | 114.111 | 0 | 0 | $0 |
| Kathleen Reape | Yönetim kurulu üyesi | 22 Haziran 2023 A | — | 0 | 0 | $0 |
| Laura Sepp-Lorenzino | Yönetim kurulu üyesi | 22 Haziran 2023 A | — | 0 | 0 | $0 |
| Paul B Manning | 10% sahip | 17 Kasım 2023 P | 16.566.667 | 0 | 0 | $0 |
| R.A. Session II | 10% sahip | 13 Temmuz 2023 S | 8.871.747 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Paul B Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, The PBM 2025 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC | 03 Haziran 2025 | 9,80% | Değişiklik | — | SEC |
| Paul B. Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC ×3 başvurular | 21 Ağustos 2023 | — | İlk başvuru | — | SEC |
| Astellas Pharma Inc., Astellas US Holding, Inc., Astellas Gene Therapies, Inc. (f/k/a Audentes Therapeutics, Inc.) ×2 başvurular | 18 Ağustos 2023 | — | İlk başvuru | — | SEC |
| RA Session II, RA Session II, as Trustee of the Session 2020 Annuity Trust I, RA Session II, as Trustee of the Session 2020 Annuity Trust II | 05 Ekim 2020 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 44 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 1,53% | 18.665 SH | 08 Ağustos 2026 | Günlük |
| SBIO · ALPS ETF Trust | 1,02% | 282.348 NS | 31 Mayıs 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,82% | 47.669 NS | 30 Nisan 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,40% | 322.791 NS | 30 Nisan 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,32% | 522.481 NS | 30 Nisan 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 7.298 NS | 30 Nisan 2026 | N-PORT |
| IBB · iShares Trust | 0,13% | 1.949.477 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 15.639 SH | 08 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 332.492 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 257.044 SH | 08 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,09% | 2.159.516 SH | 08 Ağustos 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,08% | 154.894 NS | 30 Nisan 2026 | N-PORT |
| BIB · ProShares Trust | 0,08% | 10.128 NS | 31 Mayıs 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 48.717 NS | 30 Nisan 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,06% | 23.348 NS | 31 Mayıs 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.379.816 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,05% | 6.118.574 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,04% | 95.596 NS | 30 Nisan 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 66.429 SH | 08 Ağustos 2026 | Günlük |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 64.980 NS | 31 Mayıs 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 10.394 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 1.069.955 NS | 31 Mayıs 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 117.196 SH | 08 Ağustos 2026 | Günlük |
| TEXN · iShares Trust | 0,02% | 631 SH | 08 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | 0,02% | 9.303 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 3.043.718 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 552.457 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,02% | 8.129 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 62.485 NS | 30 Nisan 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 8.221 NS | 31 Mayıs 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 8.217 SH | 08 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 8.504 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 206 NS | 31 Mayıs 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 92.844 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 78.390 NS | 30 Nisan 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 332.315 SH | 08 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 69.995 SH | 08 Ağustos 2026 | Günlük |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 131.780 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.760 NS | 30 Nisan 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 3.045 NS | 30 Nisan 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.870 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 10.179 NS | 30 Nisan 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.141.487 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.636 SH | 08 Ağustos 2026 | Günlük |